网站大量收购独家精品文档,联系QQ:2885784924

Positron emission tomography in lung cancer diagnosis and treatment progress.doc

Positron emission tomography in lung cancer diagnosis and treatment progress.doc

  1. 1、本文档共13页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Positron emission tomography in lung cancer diagnosis and treatment progress

 PAGE \* MERGEFORMAT 13 Positron emission tomography in lung cancer diagnosis and treatment progress [Abstract] At present, China has increased the incidence of lung cancer incidence rates for malignant tumors first. Early diagnosis of lung cancer to become the key to a cure. Routine chest X ray, CT, bronchoscopy, cytology, serology and so there are limitations. In recent years, positron emission tomography (PET) in clinical application of a gradual increase, it can accurately reflect the sensitivity and lung cancer cells, abnormal metabolism, protein synthesis, DNA replication and cell proliferation, especially in the diagnosis of solitary pulmonary nodules. PET not only improve the accuracy of the diagnosis and staging of lung cancer, but also for lung cancer radiotherapy and chemotherapy program in the formulation and efficacy assess significance. In this paper, PET in lung cancer and mediastinal lymph node staging in lung cancer radiotherapy and chemotherapy as well as its application, etc. are reviewed. [Keywords:] lung cancer; PET; Diagnosis Primary lung cancer is mainly of primary bronchial cancer, cancer mortality, ranking first among Chinese cities, even if the early stage non-small cell lung cancer chemotherapy after surgery, the 5-year survival rate is only about 40% [1]. How early diagnosis of lung cancer staging, early detection of recurrence and metastasis, and rational treatment of radiotherapy and chemotherapy, as well as monitoring the efficacy of raising the survival rate of patients with lung cancer is very important. Clinical examination of the current methods used are mainly CT, bronchoscopy, cytology, serology, etc., but there are limitations, such as the qualitative diagnosis of solitary pulmonary nodules, CT sensitivity of 12% ~ 63% [2 ]; bronchoscopic biopsy and brush inspection sensitivity for lung cancer is only 70% ~ 80% [3]; CT guided lung biopsy diagnostic accuracy rate was 97%, but there are pneumothorax, bleeding and other com

您可能关注的文档

文档评论(0)

hhuiws1482 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档